“…Patient comorbidities (ASA III + IV, previous abdominal surgery, obesity, and diabetes), adrenal pathology (pheochromocytoma), tumor size (≥6 cm), and surgeons' inexperience are associated with increased operative time, conversions, complications, and length of stay [5,6,8,19,24,26]. Our study included many patients with ASA III + IV (98/160, 61.2%), previous abdominal surgery (80/160, 50%), obesity (90/160, 56.2%), diabetes (30/160, 18.8%), pheochromocytoma (39/160, 24.4%), and tumors ≥6 cm (53/160, 33.1%).…”